Editorial on the article «Natriuretic Peptide Concentrations and Echocardiography Findings in Patients with Micro-atrial Fibrillation»
https://doi.org/10.18087/cardio.2024.8.n2728
Abstract
In relation with the published article "Natriuretic Peptide Concentrations and Echocardiography Findings in Patients with Micro-atrial Fibrillation", we have issued a comment. The authors of the article addressed a widely discussed topic of "Short episodes of fast arrhythmias initially detected in records on implantable devices". Further, these episodes are studied already by Holter monitoring of different durations with assessment of their clinical significance. This is the subject of the cited article and our comment.
Supporting agencies: No conflict of interest is reported.
About the Authors
G. E. Gendlin
Pirogov Russian Research Medical University
Russian Federation
Russian Federation
Doctor of Medical Sciences, Professor of the Department of Hospital Therapy named after Academician G.I. Storozhakova of "Russian National Research Medical University named after N.I. Pirogov" Ministry of Health of the Russian Federation. 117997, Moscow, st. Ostrovityanova, 1
Moscow, Russia
A. M. Baimukanov
Buyanov Municipal Clinical Hospital
Russian Federation
Russian Federation
Candidate of Medical Sciences, cardiologist, State Budgetary Institution "City Clinical Hospital named after M. Buyanov" DZM, 115516, Moscow, st. Bakinskaya, 26
Moscow, Russia
E. I. Emelina
Pirogov Russian Research Medical University
Russian Federation
Russian Federation
Candidate of Medical Sciences, Associate Professor of the Department of Hospital Therapy named after Academician G.I. Storozhakov of "Russian National Research Medical University named after N.I. Pirogov" Ministry of Health of the Russian Federation. 117997, Moscow, st. Ostrovityanova, 1
Moscow, Russia
D. A. Paegle
Pirogov Russian Research Medical University
Russian Federation
Russian Federation
PHD student of the Department of Hospital Therapy named after. Academician G.I. Storozhakova of "Russian National Research Medical University named after N.I. Pirogov" Ministry of Health of the Russian Federation, 117997, Moscow, st. Ostrovityanova, 1
Moscow, Russia
I. G. Nikitin
Pirogov Russian Research Medical University
Russian Federation
Russian Federation
Doctor of Medical Sciences, Professor, Head of the Department of Hospital Therapy named after Academician G.I. Storozhakova of "Russian National Research Medical University named after. N.I. Pirogov" Ministry of Health of the Russian Federation. 117997, Moscow, st. Ostrovityanova, 1
Moscow, Russia
References
1. Toennis T, Bertaglia E, Brandes A, Dichtl W, Fluschnik N, De Groot JR et al. The influence of atrial high-rate episodes on stroke and cardiovascular death: an update. Europace. 2023;25(7):euad166. DOI: 10.1093/europace/euad166
2. Khan AA, Boriani G, Lip GYH. Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation? Clinical Research in Cardiology. 2020;109(4):409–16. DOI: 10.1007/s00392-019-01545-4
3. Arakelyan M.G., Bockeria L.A., Vasilieva E.Yu., Golitsyn S.P., Golukhova E.Z., Gorev M.V. et al. 2020 Clinical guidelines for Atrial fibrillation and atrial flutter. Russian Journal of Cardiology. 2021;26(7):190–260. DOI: 10.15829/1560-4071-2021-4594
4. Boriani G, Vitolo M, Imberti JF, Potpara TS, Lip GYH. What do we do about atrial high rate episodes? European Heart Journal Supplements. 2020;22(Suppl O):O42–52. DOI: 10.1093/eurheartj/suaa179
5. Gherasim L. Subclinical Atrial Fibrillation, Embolic Risk, and Anticoagulant Treatment. MAEDICA – a Journal of Clinical Medicine. 2018;13(4):261–5. DOI: 10.26574/maedica.2018.13.4.261
6. Noseworthy PA, Kaufman ES, Chen LY, Chung MK, Elkind MSV, Joglar JA et al. Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association. Circulation. 2019;140(25):e944–63. DOI: 10.1161/CIR.0000000000000740
7. Imberti JF, Bonini N, Tosetti A, Mei DA, Gerra L, Malavasi VL et al. Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation. Biology. 2022;11(3):443. DOI: 10.3390/biology11030443
8. Disertori M, Franzosi MG, Barlera S, Cosmi F, Quintarelli S, Favero C et al. Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: Data from the GISSI-AF trial. BMC Cardiovascular Disorders. 2013;13(1):28. DOI: 10.1186/1471-2261-13-28
9. Kottkamp H. Fibrotic Atrial Cardiomyopathy: A Specific Disease/Syndrome Supplying Substrates for Atrial Fibrillation, Atrial Tachycardia, Sinus Node Disease, AV Node Disease, and Thromboembolic Complications. Journal of Cardiovascular Electrophysiology. 2012;23(7):797–9. DOI: 10.1111/j.1540-8167.2012.02341.x
10. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological Substrate of Atrial Biopsies in Patients With Lone Atrial Fibrillation. Circulation. 1997;96(4):1180–4. DOI: 10.1161/01.CIR.96.4.1180
11. Kułach A, Dewerenda M, Majewski M, Lasek-Bal A, Gąsior Z. 72 hour Holter monitoring, 7 day Holter monitoring, and 30 day intermittent patient-activated heart rhythm recording in detecting arrhythmias in cryptogenic stroke patients free from arrhythmia in a screening 24 h Holter. Open Medicine. 2020;15(1):697–701. DOI: 10.1515/med-2020-0203
12. Van Gelder IC, Healey JS, Crijns HJGM, Wang J, Hohnloser SH, Gold MR et al. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. European Heart Journal. 2017;38(17):1339–44. DOI: 10.1093/eurheartj/ehx042
13. Kreimer F, Mügge A, Gotzmann M. How should I treat patients with subclinical atrial fibrillation and atrial high-rate episodes? Current evidence and clinical importance. Clinical Research in Cardiology. 2022;111(9):994–1009. DOI: 10.1007/s00392-022-02000-7
14. Becher N, Toennis T, Bertaglia E, Blomström-Lundqvist C, Brandes A, Cabanelas N et al. Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h. European Heart Journal. 2024;45(10):837–49. DOI: 10.1093/eurheartj/ehad771
15. Kirchhof P, Toennis T, Goette A, Camm AJ, Diener HC, Becher N et al. Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes. New England Journal of Medicine. 2023;389(13):1167–79. DOI: 10.1056/NEJMoa2303062
16. Potpara T, Blomstrom-Lundqvist C. Anticoagulation in patients with atrial high-rate episodes. Nature Reviews Cardiology. 2024;21(1):5–6. DOI: 10.1038/s41569-023-00963-2
Review
For citations:
Gendlin G.E., Baimukanov A.M., Emelina E.I., Paegle D.A., Nikitin I.G. Editorial on the article «Natriuretic Peptide Concentrations and Echocardiography Findings in Patients with Micro-atrial Fibrillation». Kardiologiia. 2024;64(8):64-67. https://doi.org/10.18087/cardio.2024.8.n2728
Views:
439
Email this article 
Post a Comment 
